Annovis Bio, Inc.
USD1.85
-0.01 (-0.54%)
CEO
Maria L. Maccecchini
IPO Date
2020-01-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
US
Open
$1.88
Prev. Close
$1.86
Day Low
$1.83
Day High
$1.91
52W Low
$1.54
52W High
$5.50
Market Cap
$0.04B
Volume
0.49M
| 18,849 |
| $1.80 |
| 21 May 2026 | Hoffman Michael B | director | P-Purchase | Acquired | 54,933 | $1.90 |
| 3 Apr 2026 | Hoffman Michael B | director | P-Purchase | Acquired | 713,800 | $2.10 |
| 8 Dec 2025 | Hoffman Michael B | director | P-Purchase | Acquired | 30,000 | $4.34 |
| 8 Dec 2025 | Hoffman Michael B | director | P-Purchase | Acquired | 15,000 | $4.24 |
| 25 Nov 2025 | Hoffman Michael B | director | P-Purchase | Acquired | 1,489 | $4.13 |
| 25 Nov 2025 | Hoffman Michael B | director | P-Purchase | Acquired | 9,200 | $3.85 |
| 25 Nov 2025 | Hoffman Michael B | director | P-Purchase | Acquired | 415 | $4.14 |
| 25 Nov 2025 | Hoffman Michael B | director | P-Purchase | Acquired | 28,096 | $4.15 |